Companies / TRP

TISSUE REPAIR LTD

ASX:TRPPharmaceuticals, Biotechnology & Life Sciences
60.5M shares on issueASX (delayed) · as of 28 July 2026$0.080price · delayed$4.7Mmarket cap · indicative
B
Dilution grade

Runway 2–4 quarters

Cash runway2.6 quarters of funding
Share-count growth (24m)0.0%no issuance filings since 2024
Raise cadence (24m)0 cash raises
Options & rights overhang0.0% of shares
In-the-money supply0.0% of shares
Pending proposed issuesnone

TISSUE REPAIR LTD's disclosed ordinary share count is 60M as of May 2024; listed in November 2021 and its disclosure history is short. The company has not raised capital in the 24‑month window (count 0) and has no proposed securities issues pending. There have been no new share‑issuance Appendix 2A filings lodged since January 2024. At the March 2026 quarter the company reported A$4.4M in available cash, representing 2.6 quarters of cover.

AI-generated summary of this page's cited filings · updated 28 July 2026
Email me when this grade changes
Alerts are coming soon — this opens a pre-filled email that puts you on the list.
0.0%
Max option dilution
0.0%
ITM option dilution
0
Raises · last 12 months
2.6 qtrs
Cash cover · 2–4 quarters

Shares on issue — last 2 years

Ordinary shares on issue
Weekly counts from ASX records. Dots mark cash capital raises. Latest count 60.5M per ASX (delayed) (28 July 2026).
60.2M60.5M60.7MDec 24Sept 25July 26

Cash runway

2.6 qtrs
Two to four quarters of funding at the recent spend rate.
$4.4M available cash at quarter ended 31 Mar 2026 · Runway is computed from Appendix 4C/5B filings and announced raise proceeds.
Paid plan
Cash runway history
Quarterly cash, net spend and cover trend from every Appendix 4C/5B on record up to 31 Mar 2026.
Join the waitlist

Issuance timeline

Latest 5 filings (Appendix 2A quoted issues, 3G unquoted, 3H cancellations)

DateFormSecurityTotal on issue afterSource
3 Mar 20263H · cancellationTRP : ORDINARY FULLY PAID60.5MAppendix 3H
27 Feb 20263G · unquotedTRP : ORDINARY FULLY PAID60.5MAppendix 3G
26 Nov 20253G · unquotedTRP : ORDINARY FULLY PAID60.5MAppendix 3G
13 Nov 20243G · unquotedTRP : ORDINARY FULLY PAID60.5MAppendix 3G
19 Sept 20243G · unquotedTRP : ORDINARY FULLY PAID60.5MAppendix 3G
Paid plan
Full issuance history
Every quoted and unquoted issue and cancellation on record, plus unquoted securities (Appendix 4.2).
Join the waitlist

Capital raises

No equity raises in the last 24 months.
Paid plan
Full raise history
Issue price, discount, brokers, purpose and tranche detail for every raise on record.
Join the waitlist

Pending proposed issues

No proposed issues (Appendix 3B) currently pending.

Options & convertible securities

No options or rights over unissued shares on record.

Director dealings

DateDirectorTypeSharesOptionsValueSource
26 Nov 2025Patryk KaniaOther—261k—3Y notice
26 Nov 2025Alistair McKeoughOther30k311k—3Y notice
Paid plan
Full dealing history
Every change-of-director's-interest notice on record, with direction and consideration.
Join the waitlist

Ownership

Free account
Top-20 holders & substantial holder notices
Top-20 register snapshot and substantial-holder movements, each linked to its source notice.
Sign up free — coming soon

Latest announcements

22 July 2026$PVoluntary Delisting
30 Apr 2026$PQuarterly Activities/Appendix 4C Cash Flow Report
20 Apr 2026Initial Director's Interest Notice - PS
20 Apr 2026Director Appointment
3 Mar 2026Notification of cessation of securities - TRP
27 Feb 2026Notification regarding unquoted securities - TRP
27 Feb 2026$PAppendix 4D and Half Year Report to 31 December 2025
30 Jan 2026$PQuarterly Activities/Appendix 4C Cash Flow Report
10 Dec 2025$PResponse to ASX Price Query
10 Dec 2025$PPause in Trading
1 Dec 2025Change of Director's Interest Notice - PK
26 Nov 2025Change of Director's Interest Notice - AM
26 Nov 2025Notification regarding unquoted securities - TRP
24 Nov 2025Change of Auditor
24 Nov 2025Results of Meeting
23 Nov 2025AGM Presentation
29 Oct 2025$PQuarterly Activities/Appendix 4C Cash Flow Report
22 Oct 20252025 Notice of Annual General Meeting and Proxy Form
26 Sept 20252025 Annual General Meeting Date
29 Aug 2025Appendix 4G and Corporate Governance Statement

Headlines link to the source PDFs on the ASX announcements platform. Data as of 28 July 2026.